The Impact of Chryseobacterium Species on Human Health and Well-Being

Dear Colleagues,

We are pleased to invite you to submit an article to a Special Issue of Microorganisms, with a focus on Chryseobacterium and their impact on human health and well-being. These Gram-negative bacteria are commonly isolated from environmental sources, and cause a variety of illnesses in humans, including wound infections, urinary tract infections, bacteremia, and pneumonia. Interestingly, they are one of the most prevalent genera identified in studies of the bacterial co-infection of lung tissue in deceased COVID-19 patients (far behind Acinetobacter, but ahead of most other genera). However, they are also a source of several useful enzymes, such as keratinases and extracellular amylases, and research continues into the useful biological products that can be derived from these species.

This Special Issue aims to take a deep dive into the genus Chryseobacterium, introducing readers to the genetics, genomics, evolutionary history, and ecology of this group of microorganisms, with an emphasis on both positive and negative ways in which they impact human beings and the quality of our lives. These impacts may be direct (such as infectious processes) or indirect. While descriptions of novel species are outside the scope of this journal, in-depth analyses of currently recognized species are very much encouraged. Any practical applications of isolates and/or biological products derived from them are of particular interest, and of course discussions of Chryseobacterium in the clinical setting will be an integral part of this Special Issue. The goal is to collect 10 articles, and if this number is reached the Special Issue may be printed in book form.

In this Special Issue, original research articles and reviews are welcome. Research areas may include (but are not limited to) the following: increasing prevalence of Chryseobacterium infections in healthcare settings, case reports/case studies of Chryseobacterium infections in humans, roles of Chryseobacterium in agriculture, food production and/or food spoilage, industrial applications of enzymes derived from Chryseobacterium species, use of Chryseobacterium species in the bio-remediation of environmental pollutants, and the potential of specific isolates as pre-biotics or pro-biotics to promote human health and longevity.

We look forward to receiving your contributions.

Dr. Ainsley C. Nicholson
Prof. Dr. Celia J. Hugo
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Microorganisms is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• Chryseobacterium
• human
• clinical
• environment
• health
• genomics
• applications